{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ01216",
      "entity_text" : "LXR",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uniprot:P36956",
      "entity_text" : "Srebf1",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "T0 treatment leads to decreases in chromatin accessibility at targets of LXR repression, such as Il1b (XREF_FIG), and moderate increases in chromatin accessibility at LXR targets, such as Srebf1 (XREF_FIG).",
  "reading_complete" : "2020-08-09T07:25:15Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-09T07:22:33Z",
  "trigger" : "repression",
  "evidence" : [ "LXR repression, such as Il1b ( XREF_FIG ), and moderate increases in chromatin accessibility at LXR targets, such as Srebf1" ],
  "pmc_id" : "6446575",
  "score" : 0
}